Innovotech Inc (IOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Innovotech Inc (IOT) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$50.75K ≈ $36.71K USD) by net assets (CA$3.25 Million ≈ $2.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Innovotech Inc market cap and net worth for the company's overall valuation and market capitalisation.
Innovotech Inc - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Innovotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Innovotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Innovotech Inc ranked by their cash flow conversion efficiency. Explore IOT cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Forza X1 Inc
NASDAQ:FRZA
|
-0.075x |
|
NEOMETALS LTD SP.ADS/10
F:9R91
|
N/A |
|
Albion Technology & General VCT PLC
LSE:AATG
|
-0.004x |
|
Haffner Energy SA
PA:ALHAF
|
-0.330x |
|
Golden Goliath Resources Ltd.
V:GNG
|
-0.603x |
|
TRU PRECIOUS METALS CORP.
F:706
|
0.054x |
|
CubicFarm Systems Corp
V:CUB
|
0.012x |
|
GLOBAL UAV TECHS
F:YAB
|
0.036x |
Annual Cash Flow Conversion Efficiency for Innovotech Inc (2003–2025)
The table below shows the annual cash flow conversion efficiency of Innovotech Inc from 2003 to 2025. View Innovotech Inc (IOT) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$3.65 Million ≈ $2.64 Million |
CA$-62.35K ≈ $-45.11K |
-0.017x | +45.09% |
| 2024-12-31 | CA$2.62 Million ≈ $1.90 Million |
CA$-81.64K ≈ $-59.06K |
-0.031x | +86.37% |
| 2023-12-31 | CA$998.60K ≈ $722.37K |
CA$-228.08K ≈ $-164.99K |
-0.228x | -215.91% |
| 2022-12-31 | CA$1.06 Million ≈ $764.99K |
CA$208.39K ≈ $150.75K |
0.197x | +826.07% |
| 2021-12-31 | CA$1.18 Million ≈ $851.37K |
CA$25.04K ≈ $18.12K |
0.021x | -92.17% |
| 2020-12-31 | CA$644.98K ≈ $466.57K |
CA$175.24K ≈ $126.76K |
0.272x | -65.07% |
| 2019-12-31 | CA$98.09K ≈ $70.95K |
CA$76.30K ≈ $55.19K |
0.778x | +125.90% |
| 2018-12-31 | CA$93.47K ≈ $67.61K |
CA$-280.75K ≈ $-203.09K |
-3.004x | -243.54% |
| 2017-12-31 | CA$181.51K ≈ $131.30K |
CA$-158.69K ≈ $-114.80K |
-0.874x | -45878.85% |
| 2016-12-31 | CA$-1.22 Million ≈ $-881.43K |
CA$2.32K ≈ $1.68K |
-0.002x | +95.34% |
| 2015-12-31 | CA$-1.00 Million ≈ $-725.51K |
CA$40.90K ≈ $29.58K |
-0.041x | -135.58% |
| 2014-12-31 | CA$-765.66K ≈ $-553.87K |
CA$-87.75K ≈ $-63.48K |
0.115x | -88.37% |
| 2013-12-31 | CA$-569.33K ≈ $-411.85K |
CA$-560.96K ≈ $-405.79K |
0.985x | +6432.59% |
| 2003-12-31 | CA$836.94K ≈ $605.43K |
CA$-13.02K ≈ $-9.42K |
-0.016x | -171.08% |
| 2003-09-30 | CA$841.40K ≈ $608.65K |
CA$18.42K ≈ $13.32K |
0.022x | -- |
About Innovotech Inc
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more